CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

Nature Biotechnology
Daniella HerszfeldMartin Pera

Abstract

The application of human embryonic stem (hES) cells in regenerative medicine will require rigorous quality control measures to ensure the safety of hES cell-derived grafts. During propagation in vitro, hES cells can acquire cytogenetic abnormalities as well as submicroscopic genetic lesions, such as small amplifications or deletions. Many of the genetic abnormalities that arise in hES cell cultures are also implicated in human cancer development. The causes of genetic instability of hES cells in culture are poorly understood, and commonly used cytogenetic methods for detection of abnormal cells are capable only of low-throughput analysis on small numbers of cells. The identification of biomarkers of genetic instability in hES cells would greatly facilitate the development of culture methods that preserve genomic integrity. Here we show that CD30, a member of the tumor necrosis factor receptor superfamily, is expressed on transformed but not normal hES cells, and that CD30 expression protects hES cells against apoptosis.

References

Oct 1, 1989·Differentiation; Research in Biological Diversity·M F PeraJ M Parrington
Apr 3, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M F PeraD P Cerretti
Nov 6, 1998·Science·J A ThomsonJ M Jones
Nov 25, 1998·Seminars in Immunology·R Horie, T Watanabe
Dec 28, 1999·Reproduction, Fertility, and Development·M F Pera, D Herszfeld
Mar 23, 2000·The Journal of Pathology·H DürkopH Stein
Apr 5, 2000·Nature Biotechnology·B E ReubinoffA Bongso
Oct 3, 2001·Nature Biotechnology·C XuM K Carpenter
Jun 5, 2003·Nature Biotechnology·Svetlana O DoroninaPeter D Senter
Dec 9, 2003·Nature Biotechnology·Jonathan S DraperPeter W Andrews
Dec 31, 2003·Methods in Enzymology·Martin F PeraAndrew L Laslett
Mar 5, 2004·Journal of Cell Science·Martin F PeraChristine Mummery
Mar 5, 2004·The New England Journal of Medicine·Chad A CowanDouglas A Melton
Apr 3, 2004·Nature Biotechnology·Jeremy J BuzzardAlan Colman
Mar 2, 2005·Nature Reviews. Cancer·J Wolter Oosterhuis, Leendert H J Looijenga
Jul 9, 2005·Nature Biotechnology·Peter W AndrewsUNKNOWN Steering Committee of the International Stem Cell Initiative
Sep 6, 2005·Nature Genetics·Anirban MaitraAravinda Chakravarti
Sep 15, 2005·Human Molecular Genetics·Tariq EnverPeter W Andrews

❮ Previous
Next ❯

Citations

Jun 4, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Morag H StewartMickie Bhatia
Nov 24, 2007·Cell and Tissue Research·Asuka MorizanePatrik Brundin
Oct 22, 2008·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Hye Won SeolShin Yong Moon
Aug 24, 2011·Journal of Neuro-oncology·Siyi WanggouCaiping Ren
Dec 5, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·So Gun HongThomas Winkler
Nov 26, 2008·Nature Biotechnology·Claudia SpitsKaren Sermon
Jan 6, 2009·Nature Biotechnology·Tamra E Werbowetski-OgilvieMickie Bhatia
Mar 31, 2010·Nature Biotechnology·Debora SteinerBenjamin Reubinoff
Sep 12, 2012·Nature Biotechnology·Justine J CunninghamLeendert H J Looijenga
Feb 9, 2007·Nature Biotechnology·Duncan E C BakerPeter W Andrews
Aug 8, 2013·Nature Medicine·Andrew S LeeJoseph C Wu
Jul 25, 2006·Nature Methods·Tenneille E LudwigJames A Thomson
Sep 12, 2012·Nature Reviews. Genetics·Riikka J LundRiitta Lahesmaa
Sep 6, 2007·Stem Cells and Development·Rishi Sharma, Ram Raghubir
Dec 12, 2012·Human Reproduction Update·H T NguyenC Spits
Mar 6, 2007·BMC Developmental Biology·Andrew L LaslettMartin F Pera
Nov 24, 2011·PloS One·Thien TraMark Prescott
Nov 12, 2009·Regenerative Medicine·Nathalie LefortMarc Peschanski
Mar 18, 2008·Neurosurgical Focus·Eftekhar EftekharpourMichael G Fehlings
May 9, 2008·Regenerative Medicine·Sean C BendallMickie Bhatia
Jul 13, 2007·Stem Cell Reviews·M William LenschThorsten M Schlaeger
Oct 6, 2007·Stem Cell Reviews·C Grandela, E Wolvetang
Sep 18, 2007·Stem Cell Reviews·Amander T Clark
Mar 20, 2010·Stem Cell Reviews and Reports·Sergey V AnisimovAna S Correia
Sep 12, 2006·Médecine sciences : M/S·Chantal Cerdan, Mickie Bhatia
Jan 22, 2014·The Journal of Cell Biology·Uri WeissbeinUri Ben-David
Sep 29, 2009·International Journal of Pharmaceutics·Olivier Preynat-SeauveKarl-Heinz Krause
Jul 19, 2008·Trends in Molecular Medicine·Tamra E Werbowetski-Ogilvie, Mickie Bhatia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis